標(biāo)題: Titlebook: Atrial Fibrillation, a Treatable Disease?; J. H. Kingma,N. M. Hemel,K. I. Lie Book 1992 Springer Science+Business Media Dordrecht 1992 Abl [打印本頁(yè)] 作者: miserly 時(shí)間: 2025-3-21 20:02
書目名稱Atrial Fibrillation, a Treatable Disease?影響因子(影響力)
書目名稱Atrial Fibrillation, a Treatable Disease?影響因子(影響力)學(xué)科排名
書目名稱Atrial Fibrillation, a Treatable Disease?網(wǎng)絡(luò)公開度
書目名稱Atrial Fibrillation, a Treatable Disease?網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Atrial Fibrillation, a Treatable Disease?被引頻次
書目名稱Atrial Fibrillation, a Treatable Disease?被引頻次學(xué)科排名
書目名稱Atrial Fibrillation, a Treatable Disease?年度引用
書目名稱Atrial Fibrillation, a Treatable Disease?年度引用學(xué)科排名
書目名稱Atrial Fibrillation, a Treatable Disease?讀者反饋
書目名稱Atrial Fibrillation, a Treatable Disease?讀者反饋學(xué)科排名
作者: 厚顏無(wú)恥 時(shí)間: 2025-3-21 22:48
l investigations of electrophysiology impossible during AF. However, valuable insights can be gained from patients with paroxysmal atrial fibrillation (PAF). In particular, observations regarding the timing of attacks in such patients have highlighted the possible aetiological role of the autonomic 作者: endarterectomy 時(shí)間: 2025-3-22 02:15
Book 1992apbetween theory, experiment and the clinic. Emphasis is therefore onthe selection of the optimal approach, including pharmacotherapy,catheter ablation, pacemaker and surgical therapy, based on thecurrent scientific insights in the mechanism and prevention of atrialfibrillation. .作者: 猜忌 時(shí)間: 2025-3-22 08:05 作者: 朝圣者 時(shí)間: 2025-3-22 11:42
Sinus Rhythm, the Autonomic Nervous System, and Quality of Lifel investigations of electrophysiology impossible during AF. However, valuable insights can be gained from patients with paroxysmal atrial fibrillation (PAF). In particular, observations regarding the timing of attacks in such patients have highlighted the possible aetiological role of the autonomic 作者: Diskectomy 時(shí)間: 2025-3-22 13:00
Atrial anatomy plays a role in heart physiology by controlling, to an extent, heart rate, ventricular filling and myocardial contractility. Atrial fibrillation disrupts atrial functional anatomy by abolishing sinus node chronotropic function, atrial contraction, and by impairing AV nodal physiology.作者: 谷物 時(shí)間: 2025-3-22 18:42 作者: 出處 時(shí)間: 2025-3-22 21:39 作者: 搖擺 時(shí)間: 2025-3-23 03:48 作者: Moderate 時(shí)間: 2025-3-23 08:40
https://doi.org/10.1007/978-94-011-1816-3Ablation; Bypass; anatomy; atrial fibrillation; embolism作者: Ovulation 時(shí)間: 2025-3-23 12:31
978-94-010-4801-9Springer Science+Business Media Dordrecht 1992作者: Aspirin 時(shí)間: 2025-3-23 14:27 作者: Aids209 時(shí)間: 2025-3-23 19:37 作者: 才能 時(shí)間: 2025-3-24 00:00 作者: GONG 時(shí)間: 2025-3-24 06:03
Die Performance von Futures Funds, years of age. In cardiac patients the prevalence is about 4%, and up to 40% in patients with overt congestive heart failure[1–3]. In the Framingham study the overall incidence in both sexes of developing atrial fibrillation was two per thousand in each biennium, rising sharply with age[4]. Rheumati作者: Optimum 時(shí)間: 2025-3-24 08:45
Futures Funds und Managed Futuresin man. Atrial fibrillation, “the grandfather of cardiac arrhythmias”, is prevalent in 0.4% of the general population and is estimated to effect 2% to 4% of adults >60 years of age. Depending on the degree of congestive heart failure the prevalence of atrial fibrillation in the cardiac population ma作者: 瑪瑙 時(shí)間: 2025-3-24 12:57
aintenance of sinus rhythm is a challenge to the clinician, since these arrhythmias have a high tendency to recur[1,2]. In addition, arrhythmic and hemodynamic complications associated with a recurrence, hazards of prophylactic drug therapy and risk of postcardioversion stroke are among the problems作者: defenses 時(shí)間: 2025-3-24 15:40 作者: Resection 時(shí)間: 2025-3-24 22:59 作者: entrance 時(shí)間: 2025-3-25 01:39 作者: 昆蟲 時(shí)間: 2025-3-25 05:29
uction of the term tachycardiomyopathy, indicating that deterioration in cardiac function can be caused by the arrhythmia per se and that normal heart function may be restored by cure of the arrhythmia.作者: 大喘氣 時(shí)間: 2025-3-25 10:33 作者: Genome 時(shí)間: 2025-3-25 12:59
venty-eight patients who underwent total pneumonectomy, five developed transient atrial fibrillation (AF) and two atrial flutter, most episodes occurring within two weeks of surgery[1]. None of these patients had organic heart disease and none subsequently developed a sustained atrial arrhythmia. Si作者: 過份好問 時(shí)間: 2025-3-25 16:49
lutter and seldom as atrial tachycardia[1]. These transient postoperative supraventricular tachyarrhythmias are considered a form of paroxysmal atrial arrhythmia of recent onset. Atrial tachyarrhythmias commonly complicate the early postoperative course after cardiac surgery. Atrial arrhythmias occu作者: chronicle 時(shí)間: 2025-3-25 22:15 作者: 變態(tài) 時(shí)間: 2025-3-26 02:27 作者: 強(qiáng)制令 時(shí)間: 2025-3-26 05:51 作者: EXALT 時(shí)間: 2025-3-26 08:37
Atrial Fibrillation, a Treatable Disease?978-94-011-1816-3Series ISSN 0166-9842 作者: Arrhythmia 時(shí)間: 2025-3-26 13:41
uction of the term tachycardiomyopathy, indicating that deterioration in cardiac function can be caused by the arrhythmia per se and that normal heart function may be restored by cure of the arrhythmia.作者: obnoxious 時(shí)間: 2025-3-26 20:42
Characteristics of Patients with Chronic Atrial Fibrillation and the Prediction of Successful DC Elec heart disease and cardiac failure were the most powerful predictive precursors, with at least a sixfold excess risk. Men with coronary artery disease had a statistically significant doubled risk of developing chronic atrial fibrillation, whereas women did not have an increased risk[5].作者: Foreshadow 時(shí)間: 2025-3-26 23:20 作者: 龍蝦 時(shí)間: 2025-3-27 01:07
Drugs after Cardioversion to Prevent Relapses of Chronic Atrial Fibrillation or Flutter threatening these patients. This chapter deals with the pharmacologic treatment modalities in the prevention of recurrences of chronic atrial fibrillation and flutter. Prevention of thromboembolism is discussed elsewhere in this book.作者: 減震 時(shí)間: 2025-3-27 07:16
The ’Corridor’ Operation as an Alternative in the Treatment of Atrial Fibrillationial fibrillation today two alternative electrophysiologic interventions are available: His-bundle ablation followed by chronic cardiac pacing[3,4], or the surgical exclusion of the anatomical substrate of atrial fibrillation[5,6,7].6作者: 吃掉 時(shí)間: 2025-3-27 11:31 作者: 好色 時(shí)間: 2025-3-27 16:20
Management of Paroxysmal Atrial Fibrillation and Atrial Flutter Shortly after Coronary Artery Bypassrring immediately after operation can jeopardize hemodynamic stability or lead to intolerable symptoms. These arrhythmias are usually benign, but could require additional drug therapy, cardiac pacing or even electrical cardioversion.作者: Genteel 時(shí)間: 2025-3-27 19:58 作者: oracle 時(shí)間: 2025-3-28 00:28 作者: 絆住 時(shí)間: 2025-3-28 03:23 作者: encomiast 時(shí)間: 2025-3-28 06:48
https://doi.org/10.1007/978-3-642-93018-8 it encounters tissue in a more or less advanced state of recovery. It may divide again or combine with a neighbor; it may be expected to fluctuate in size and change in direction. Its course, though determined by the excitability or refractoriness of surrounding tissue, would appear to be as random as Brownian motion”[2].作者: CHASE 時(shí)間: 2025-3-28 14:17 作者: 吹牛者 時(shí)間: 2025-3-28 16:15
From Experiment to Therapeutic Innovation in Atrial Fibrillation and Fluttersion illustrates very well this disparity: ventricular fibrillation and tachycardia are the case in animal experiments, whereas accelerated idioventricular rhythm is today recognized a marker of reperfusion following thrombolysis in human coronary arteries[2,3].作者: 戲法 時(shí)間: 2025-3-28 18:46
The Pathology of Drug Resistant Lone Atrial Fibrillation in Eleven Surgically Treated Patientsl Heart Disease or of metabolic diseases. The pathological findings suggest that cardiomyopathic changes in the atria could be the anatomical substrate for the fibrillation. We report pathological findings in eleven cases of long-standing, drug-resistant AFs treated surgically with the . operation[12–15].作者: surmount 時(shí)間: 2025-3-28 23:56
Termination of Atrial Fibrillation by Class IC Antiarrhythmic Drugs, a Paradox? it encounters tissue in a more or less advanced state of recovery. It may divide again or combine with a neighbor; it may be expected to fluctuate in size and change in direction. Its course, though determined by the excitability or refractoriness of surrounding tissue, would appear to be as random as Brownian motion”[2].作者: Lacerate 時(shí)間: 2025-3-29 03:34 作者: 正式通知 時(shí)間: 2025-3-29 10:10
0166-9842 l fibrillation than ever before. Also, there is a growing bodyof knowledge of the pathophysiologic mechanism, the pathology andepidemiology, and especially of the thrombo-embolic complications ofthis arrhythmia, which is responsible for a renewed interest of theclinician in this very common human ar作者: 并置 時(shí)間: 2025-3-29 15:21 作者: configuration 時(shí)間: 2025-3-29 19:11 作者: peptic-ulcer 時(shí)間: 2025-3-29 20:51
Episodic Treatment of Paroxysmal Atrial Fibrillationts quality of life. How to cope with the sudden onset of an attack is not only uncomfortable for the patient but a source of anxiety and concern over the ability to continue to function as usual. However, there is the old cliché: “You will have to live with it”.作者: 付出 時(shí)間: 2025-3-30 02:23
An AICD for Atrial Fibrillation?imals in whom the arrhythmia was initiated by topical application of acetyl choline and gentle traction of the atrial appendage. In the same model, 40–100 joules were needed for cardioversion with transthoracic shock. These findings relating to the success of low energy defibrillation have been corroborated by a number of other investigators[2,3].作者: COM 時(shí)間: 2025-3-30 07:24 作者: larder 時(shí)間: 2025-3-30 10:18 作者: 沒花的是打擾 時(shí)間: 2025-3-30 15:04 作者: 反對(duì) 時(shí)間: 2025-3-30 18:23 作者: blackout 時(shí)間: 2025-3-30 21:16 作者: athlete’s-foot 時(shí)間: 2025-3-31 04:11
rring immediately after operation can jeopardize hemodynamic stability or lead to intolerable symptoms. These arrhythmias are usually benign, but could require additional drug therapy, cardiac pacing or even electrical cardioversion.作者: aspect 時(shí)間: 2025-3-31 07:09 作者: FOVEA 時(shí)間: 2025-3-31 12:37
Risk and Prevention of Embolism in Atrial Fibrillationty of antithrombotic therapy in nonrheumatic atrial fibrillation, several randomized trials have been initiated in recent years. Some of these trials have now been completed[6,8,9,10]. The results of these studies and an approach to the application of antithrombotic therapy based on pathogenesis will be discussed.
